ID   HeLa/SN1
AC   CVCL_JQ52
DR   Wikidata; Q54882701
RX   PubMed=19201079;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 7
//
RX   PubMed=19201079; DOI=10.1016/j.canlet.2008.12.033;
RA   Takara K., Kitada N., Yoshikawa E., Yamamoto K., Horibe S.,
RA   Sakaeda T., Nishiguchi K., Ohnishi N., Yokoyama T.;
RT   "Molecular changes to HeLa cells on continuous exposure to SN-38, an
RT   active metabolite of irinotecan hydrochloride.";
RL   Cancer Lett. 278:88-96(2009).
//